Thirty-two people walked into a London hospital with operable bowel cancer. They received nine weeks of a single immunotherapy drug, pembrolizumab, before undergoing surgery. Nearly three years later, ...
Morning Overview on MSN
A new drug just wiped out detectable bowel cancer in 59% of trial patients — and nearly three years later, not one has seen the disease come back
Every year, more than 1.9 million people worldwide are diagnosed with colorectal cancer. For those whose tumors are caught at ...
Alliance A212101: Evaluation of Provider vs. Patient Mediated Cascade Genetic Testing of First-Degree Relatives of Patients with Newly Diagnosed Colorectal Cancer Heather Hampel, MS, CGC, of City of ...
A short burst of immunotherapy before surgery is delivering surprisingly powerful results for a specific type of colorectal cancer. Patients in a UK-led trial who received just nine weeks of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results